RPHM

Reneo Pharmaceuticals, Inc.

1.66 USD
0.00 (0.00%)
Last updated
This page is just a preview of the data found in TrendSpider’s full version

Reneo Pharmaceuticals, Inc. stock is down -0.6% since 30 days ago. The next earnings date is Aug 8, 2024. The company has had below-average volume in the last 30 days. Its seasonality going into this month shows a chance of a red month, as 0% of the previous 3 May’s closed higher than April. 0% of analysts rate it a buy.

About Reneo Pharmaceuticals, Inc.

Reneo Pharmaceuticals, Inc. focuses on the development of therapies for patients with rare genetic mitochondrial diseases. It develops REN001, a selective peroxisome proliferator-activated receptor delta agonist, which is in Phase IIb clinical trial.